ELEUTERIO R ALILIN

Allopathic & Osteopathic Physicians|Family Medicine WINTER PARK, FL NPI 1982775367

General Payments — all program years on this page

$933.61

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $312.02 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $312.0216

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $83.675
Lilly USA, LLC $64.053
Acerta Pharma LLC $60.783
Bayer HealthCare Pharmaceuticals Inc. $42.612
Abbott Laboratories $21.911
DEXCOM, INC. $21.581
GlaxoSmithKline, LLC. $17.421

By program year

Program yearAmountRecords
2018 $100.001
2019 $156.663
2020 $90.293
2021 $15.021
2022 $79.205
2023 $180.4211
2024 $312.0216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086199154 Bayer Healthcare Pharmaceuticals Inc. $17.48 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086261764 Bayer Healthcare Pharmaceuticals Inc. $25.13 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096595132 Novo Nordisk Inc $16.12 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096728186 Novo Nordisk Inc $14.22 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096976111 Novo Nordisk Inc $17.10 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096992953 Novo Nordisk Inc $20.03 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097095554 Novo Nordisk Inc $16.20 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104347694 AstraZeneca Pharmaceuticals LP $19.08 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104369601 AstraZeneca Pharmaceuticals LP $13.29 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104526800 AstraZeneca Pharmaceuticals LP $28.41 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116473375 GlaxoSmithKline, LLC. $17.42 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125371967 Abbott Laboratories $21.91 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134968225 Lilly USA, LLC $23.76 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134968227 Lilly USA, LLC $16.98 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136162653 Lilly USA, LLC $23.31 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153298085 Dexcom, Inc. $21.58 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.